irinotecan has been researched along with luteolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeing, T; Cury, BJ; da Silva, LM; de Andrade, SF; de Souza, P; Desreumax, P; Dubuqoy, L; Ferreira Dos Anjos, M; Mariano, LNB; Quintão, NLM; Somensi, LB; Speca, S | 1 |
| Bertin, B; Boeing, T; de Souza, P; Desreumax, P; Dubuqoy, L; Faloni de Andrade, S; Mena, AM; Mota da Silva, L; Speca, S | 1 |
2 other study(ies) available for irinotecan and luteolin
| Article | Year |
|---|---|
Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camptothecin; Intestinal Mucosa; Irinotecan; Luteolin; Mice; Mucositis | 2020 |
The PPARγ-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Caco-2 Cells; Down-Regulation; Heme Oxygenase-1; Humans; Interleukin-1beta; Irinotecan; Luteolin; Nitric Oxide Synthase Type II; PPAR gamma; Superoxide Dismutase; Up-Regulation | 2022 |